Article
Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
Clinical laboratory - 1 Jan 2010
Klemm Marco, Eidens Moritz, Lorenz Marion, Prause Stefan, Weise Alexander, Dahmen Norbert, Forst Thomas, Pfützner Andreas
Abstract excerpt
BACKGROUND: The cytochrome P450 1A2 (CYP1A2) gene encodes one of the most important enzymes of the Phase I drug metabolism, which is involved in the metabolism of many lipophilic xenobiotics, such as haloperidol, theophylline, phenacetine, and others. The recently discovered single nucleotide polymorphisms CYP1A2*1C (-3860G-->A) in the 5' flanking region of the gene and CYP1A2*1F (-163C-->A) in intron 1 seem to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
